Electrocardiographic features that militate against early hospital discharge after transcatheter aortic valve replacement
An 84-year-old woman was referred for transcatheter aortic valve replacement (TAVR) after severe symptomatic aortic stenosis (valve area, 0.9 cm2; peak and mean transaortic pressure gradients of 63 mm Hg and 32 mm Hg, respectively). She had a medical history of renal cell carcinoma after nephrectomy with a creatinine level of 1.7 mg/L. Echocardiography showed preserved left ventricular function and mild to moderate aortic and mitral regurgitation. Normal coronary arteries were found on coronary angiography before TAVR. (Source: Heart Rhythm)
Source: Heart Rhythm - February 8, 2024 Category: Cardiology Authors: Oren Yagel, Jeremy Ben-Shoshan, Bernard Belhassen Tags: ECG Corner Source Type: research
Caudal Tilt Ultrasound: Are Things Looking Up for Axillary Vein Access?
The choice of vascular access for transvenous lead implantation must balance ease of vascular access against radiation exposure and risk of procedure-related complications. Although subclavian vein puncture has a well-defined anatomic landmark and enables access to a large caliber vein, it carries risks of pneumothorax, inadvertent arterial puncture, and lead dysfunction due to subclavian crush syndrome. In contrast, cephalic vein cutdown avoids pneumothorax and reduces fluoroscopy through direct visualization of the vein, but is limited by occasional absence of the vein, difficulty passing multiple leads, increased proced...
Source: Heart Rhythm - February 8, 2024 Category: Cardiology Authors: Anand Thiyagarajah, Dennis H. Lau Source Type: research
ECG Features that Militate Against Early Hospital Discharge after Transcatheter Aortic Valve Replacement
An 84-year-old woman was referred for transcatheter aortic valve replacement (TAVR) following severe symptomatic aortic stenosis (valve area 0.9 cm2, peak and mean transaortic pressure gradients of 63 and 32 mmHg, respectively). She had a medical history of renal cell carcinoma post nephrectomy with a creatinine level of 1.7mg/l. (Source: Heart Rhythm)
Source: Heart Rhythm - February 8, 2024 Category: Cardiology Authors: Oren Yagel, Jeremy Ben-Shoshan, Bernard Belhassen Source Type: research
Pulsed Field Ablation for Atrial Fibrillation in real-life settings: Efficacy, Safety and Lesion Durability in Patients with Recurrences
Initial findings from feasibility studies on pulsed field ablation (PFA) in the treatment of atrial fibrillation (AF) indicated high rates of efficacy and pulmonary vein (PV) isolation (PVI) durability upon systematic remapping. Nonetheless, there remains a shortage of data regarding effectiveness, lesion durability and safety of the procedure beyond the scope of feasibility studies. This analysis was conducted to assess the efficacy, safety and lesion durability associated with PFA for AF in real-life settings. (Source: Heart Rhythm)
Source: Heart Rhythm - February 8, 2024 Category: Cardiology Authors: Karim Benali, Konstantinos Vlachos, Vivek Y. Reddy, Atul Verma, Julian Chun, Jason Andrade, Laurent Macle, Antoine Da Costa, Pierre Ja ïs, Mélèze Hocini Source Type: research
Sex-specific outcomes after catheter ablation for persistent AF
Sex-specific outcomes after catheter ablation (CA) for atrial fibrillation (AF) have reported conflicting findings. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Louise Segan, David Chieng, Rose Crowley, Jeremy William, Hariharan Sugumar, Liang-Han Ling, Joshua Hawson, Sandeep Prabhu, Aleksandr Voskoboinik, Joseph B. Morton, Geoffrey Lee, Laurence D. Sterns, Matthew Ginks, Prashanthan Sanders, Jonathan M. Kalman, Source Type: research
Sex-specific outcomes after catheter ablation in persistent AF
Sex-specific outcomes after catheter ablation (CA) for atrial fibrillation (AF) have reported conflicting findings. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Louise Segan, David Chieng, Rose Crowley, Jeremy William, Hariharan Sugumar, Liang-Han Ling, Joshua Hawson, Sandeep Prabhu, Aleksandr Voskoboinik, Joseph B. Morton, Geoffrey Lee, Laurence D. Sterns, Matthew Ginks, Prashanthan Sanders, Jonathan M. Kalman, Source Type: research
Bipolar endo-epicardial RF ablation: Animal feasibility study
Bipolar radiofrequency ablation (B-RFA) is a method used to treat the arrhythmia substrate resistant to unipolar ablation. Few studies have addressed endo-epicardial B-RFA. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Pawe ł Derejko, Izabela Janus, Piotr Kułakowski, Jacek Kuśnierz, Jakub Baran, Urszula Hangiel, Joanna Proszek, Piotr Frydrychowski, Marcin Michałek, Agnieszka Noszczyk-Nowak Source Type: research
Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial
The PRAETORIAN score estimates the risk of failure of subcutaneous implantable cardioverter-defibrillator (S-ICD) therapy by using generator and lead positioning on bidirectional chest radiographs. The PRAETORIAN-DFT trial investigates whether PRAETORIAN score calculation is noninferior to defibrillation testing (DFT) with regard to first shock efficacy in spontaneous events. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Reinoud E. Knops, Mikhael F. El-Chami, Christelle Marquie, Peter Nordbeck, Anne-Floor B.E. Quast, Roland.R. Tilz, Tom F. Brouwer, Pier D. Lambiase, Christopher J. Cassidy, Lucas V.A. Boersma, Martin C. Burke, Shari Pepplinkhuizen, Jolien A. de Veld, Anouk Source Type: research
Association between daytime napping and incident arrhythmias: A prospective cohort study and mendelian randomization analysis
Emerging evidence has linked daytime napping with the risk of cardiovascular events. Cardiac arrhythmias are considered an early clinical stage for cardiovascular diseases. However, whether napping frequency is associated with incident arrhythmias remains unknown. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Qing-Yuan Gao, Hai-Feng Zhang, Jing-Wei Gao, Jie-Wen Cai, Qian Chen, Si You, Zhi-Teng Chen, Da-Chuan Guo, Shu-Tai Li, Qing-Yun Hao, Pin-Ming Liu, Jing-Feng Wang, Yang-Xin Chen Source Type: research
Association between Daytime Napping and Incident Arrhythmias: A Prospective Cohort Study and a Mendelian Randomization Analysis
Emerging evidence has linked daytime napping with the risk of cardiovascular events. Cardiac arrhythmias are considered as early-stage clinical stage for cardiovascular diseases. However, whether napping frequency is associated with incident arrhythmias remains unknown. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Qing-Yuan Gao, Hai-Feng Zhang, Jing-Wei Gao, Jie-Wen Cai, Qian Chen, Si You, Zhi-Teng Chen, Da-Chuan Guo, Shu-Tai Li, Qing-Yun Hao, Pin-Ming Liu, Jing-Feng Wang, Yang-Xin Chen Source Type: research
The predictive value of the PRAETORIAN score for defibrillation test success in subcutaneous ICD patients: a sub-analysis of the PRAETORIAN-DFT trial
The PRAETORIAN score estimates the risk of failure of subcutaneous implantable cardioverter defibrillator (S-ICD) therapy, using generator and lead positioning on bidirectional chest radiographs. The PRAETORIAN-DFT trial investigates whether PRAETORIAN score calculation is non-inferior to defibrillation testing (DFT), with regard to first shock efficacy in spontaneous events. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Reinoud E. Knops, Mikhael F. El-Chami, Christelle Marquie, Peter Nordbeck, Anne-Floor B.E. Quast, Roland.R. Tilz, Tom F. Brouwer, Pier D. Lambiase, Christopher J. Cassidy, Lucas V.A. Boersma, Martin C. Burke, Shari Pepplinkhuizen, Jolien A. de Veld, Anouk Source Type: research
Duration of Atrial Fibrillation: How Much is Too Much?
International guidelines categorise atrial fibrillation (AF) largely upon duration: paroxysmal (PAF; intermittent episodes lasting12 months) or permanent (where patient and clinician agree to discontinue the pursuit of rhythm control and accept continuous AF)(1). Whilst catheter ablation (CA) of AF is an established, guideline-recommended approach to rhythm control(1), it is recognised that outcomes are worse for those with PeAF or LSPeAF, as compared with PAF(2). (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Peter Calvert, Mark T. Mills, Dhiraj Gupta Source Type: research
Sex specific outcomes following catheter ablation in persistent AF
Sex-specific outcomes following AF ablation(CA) have reported conflicting findings. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Louise Segan, David Chieng, Rose Crowley, Jeremy William, Hariharan Sugumar, Liang-Han Ling, Joshua Hawson, Sandeep Prabhu, Aleksandr Voskoboinik, Joseph B. Morton, Geoffrey Lee, Laurence D. Sterns, Matthew Ginks, Prashanthan Sanders, Jonathan M. Kalman, Source Type: research
Bipolar endo-epicardial RF ablation - animal feasibility study
The aim of the study was to evaluate chronic lesions resulting from endo-epicardial bipolar radio-frequency (RF) ablation (B-RFA) and determine optimal settings for such procedures in an animal model. (Source: Heart Rhythm)
Source: Heart Rhythm - February 7, 2024 Category: Cardiology Authors: Pawe ł Derejko, Izabela Janus, Piotr Kułakowski, Jacek Kuśnierz, Jakub Baran, Urszula Hangiel, Joanna Proszek, Piotr Frydrychowski, Marcin Michałek, Agnieszka Noszczyk-Nowak Source Type: research
Adeno-associated virus –mediated gene therapy for cardiac tachyarrhythmia: A systematic review and meta-analysis
Cardiac tachyarrhythmia presents a significant health care challenge, causing notable morbidity and mortality. Conventional treatments have limitations and potential risks, resulting in an elevated disease burden. Adeno-associated virus (AAV) –mediated gene therapy holds promise as a potential future treatment option. Therefore, we aimed to provide a measured overview of the latest developments in this rapidly growing field. PubMed and Embase databases were searched up to January 2024. Studies that employed AAV as a vector for delivery of therapeutic agents to treat cardiac tachyarrhythmia were included. (Source: Heart Rhythm)
Source: Heart Rhythm - February 6, 2024 Category: Cardiology Authors: Juan Mundisugih, Saurabh Kumar, Eddy Kizana Tags: Contemporary Review Source Type: research
